{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:43:14Z","timestamp":1790811794091,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007241","name":"Universite Paris-Sud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007486","name":"Universit\u00e9 Paris-Sud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijantimicag.2021.106364","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T16:05:09Z","timestamp":1621872309000},"page":"106364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries. A systematic review"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2958-3436","authenticated-orcid":false,"given":"Lison","family":"Rambli\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Delarocque-Astagneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bich-Tram","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2021.106364_bib0001","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(11)70054-8","article-title":"Non-prescription antimicrobial use worldwide: a systematic review","volume":"11","author":"Morgan","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0003","series-title":"Trachoma control. A guide for programme managers","year":"2006"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0004","series-title":"The use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children","year":"2013"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0005","first-page":"1543","article-title":"Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances","volume":"6","author":"Francino","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0007","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/cid\/ciz893","article-title":"Antimicrobial resistance following azithromycin mass drug administration: potential surveillance strategies to assess public health impact","volume":"70","author":"Mack","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0008","unstructured":"World Bank Country and Lending Groups. Country classification. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups [Accessed 17 April 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0009","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S1473-3099(18)30444-4","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review","volume":"19","author":"O'Brien","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0010","doi-asserted-by":"crossref","first-page":"ofy289","DOI":"10.1093\/ofid\/ofy289","article-title":"Effect of commonly used pediatric antibiotics on gut microbial diversity in preschool children in Burkina Faso: a randomized clinical trial","volume":"5","author":"Oldenburg","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/cid\/ciz455","article-title":"Gut resistome after oral antibiotics in preschool children in Burkina Faso: a randomized controlled trial","volume":"70","author":"Oldenburg","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0012","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4269\/ajtmh.18-0342","article-title":"Effect of antibiotics on short-term growth among children in Burkina Faso: a randomized trial","volume":"99","author":"Si\u00e9","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0013","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in sub-Saharan Africa","volume":"378","author":"Keenan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0014","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/cid\/ciy973","article-title":"Mass oral azithromycin for childhood mortality: timing of death after distribution in the MORDOR trial","volume":"68","author":"Porco","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0015","first-page":"574","article-title":"Morbidity in a longitudinal cohort of children residing in villages randomized to biannual treatment with azithromycin versus placebo","volume":"70","author":"West","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0016","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1817213","article-title":"Longer-term assessment of azithromycin for reducing childhood mortality in Africa","volume":"380","author":"Keenan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0017","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMc1901535","article-title":"Macrolide resistance in MORDOR I\u2014a cluster-randomized trial in Niger","volume":"380","author":"Doan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0018","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41591-019-0533-0","article-title":"Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution","volume":"25","author":"Doan","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0019","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4269\/ajtmh.19-0500","article-title":"Impact of biannual azithromycin on anemia in preschool children in Kilosa District, Tanzania: a cluster-randomized clinical trial","volume":"103","author":"Bloch","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0020","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4269\/ajtmh.19-0547","article-title":"Malaria parasitemia and nutritional status during the low transmission season in the presence of azithromycin distribution among preschool children in Niger","volume":"103","author":"Arzika","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002835","article-title":"Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: a cluster-randomized, placebo-controlled trial","volume":"16","author":"Arzika","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0022","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1811400","article-title":"Effect of adding azithromycin to seasonal malaria chemoprevention","volume":"380","author":"Chandramohan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0023","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1507024","article-title":"Routine amoxicillin for uncomplicated severe acute malnutrition in children","volume":"374","author":"Isanaka","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1179\/146532808X270635","article-title":"Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin","volume":"28","author":"Dubray","year":"2008","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1202851","article-title":"Antibiotics as part of the management of severe acute malnutrition","volume":"368","author":"Trehan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0026","first-page":"1022","article-title":"Evaluation of the routine use of amoxicillin as part of the home-based treatment of severe acute malnutrition","volume":"15","author":"Trehan","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0027","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2214-109X(16)30096-1","article-title":"Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial","volume":"4","author":"Berkley","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0028","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1097\/QAD.0000000000001264","article-title":"Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis","volume":"30","author":"Prendergast","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0029","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","article-title":"Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial","volume":"364","author":"Chintu","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/515396","article-title":"The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children","volume":"44","author":"Walker","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAD.0b013e3280114ed7","article-title":"Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children","volume":"21","author":"Mulenga","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0032","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1128\/AAC.01409-09","article-title":"Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia","volume":"54","author":"Mwenya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0033","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/cid\/cir029","article-title":"Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis","volume":"52","author":"Prendergast","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0034","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1016\/S2214-109X(14)70329-8","article-title":"Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial","volume":"2","author":"Homsy","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0035","doi-asserted-by":"crossref","first-page":"d1617","DOI":"10.1136\/bmj.d1617","article-title":"Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial","volume":"342","author":"Sandison","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0036","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2471\/BLT.07.049668","article-title":"Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study","volume":"86","author":"Gill","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0037","doi-asserted-by":"crossref","first-page":"e25021","DOI":"10.1002\/jia2.25021","article-title":"Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana","volume":"20","author":"Powis","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0038","doi-asserted-by":"crossref","first-page":"e1717","DOI":"10.1016\/S2214-109X(19)30422-X","article-title":"Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial","volume":"7","author":"Daniels","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0039","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/cid\/ciz1186","article-title":"Cotrimoxazole prophylaxis increases resistance gene prevalence and \u03b1-diversity but decreases \u03b2-diversity in the gut microbiome of human immunodeficiency virus-exposed, uninfected infants","volume":"71","author":"D'Souza","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1214901","article-title":"A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa","volume":"370","author":"Bwakura-Dangarembizi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0041","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2431-14-104","article-title":"The effect of intrapartum antibiotics on early-onset neonatal sepsis in Dhaka, Bangladesh: a propensity score matched analysis","volume":"14","author":"Chan","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000191","article-title":"The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis","volume":"6","author":"van den Broek","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0043","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4269\/ajtmh.2010.10-0264","article-title":"Effect of repeated treatment of pregnant women with sulfadoxine\u2013pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial","volume":"83","author":"Luntamo","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0044","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/tmi.12074","article-title":"The effect of antenatal monthly sulphadoxine\u2013pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial","volume":"18","author":"Luntamo","year":"2013","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216536","article-title":"The impact of maternal antenatal treatment with two doses of azithromycin and monthly sulphadoxine\u2013pyrimethamine on child weight, mid-upper arm circumference and head circumference: a randomized controlled trial","volume":"14","author":"Hallamaa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0046","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/mcn.12215","article-title":"Azithromycin-containing intermittent preventive treatment in pregnancy affects gestational weight gain, an important predictor of birthweight in Papua New Guinea\u2014an exploratory analysis","volume":"12","author":"Unger","year":"2016","journal-title":"Matern Child Nutr"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12916-014-0258-3","article-title":"Sulphadoxine\u2013pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial","volume":"13","author":"Unger","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0048","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/JCM.03570-14","volume":"53","author":"Unger","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0049","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2281","article-title":"Azithromycin in labor lowers clinical infections in mothers and newborns: a double-blind trial","volume":"139","author":"Oluwalana","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.03.005","article-title":"Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial","volume":"22","author":"Roca","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206348","article-title":"Long-lasting effect of oral azithromycin taken by women during labour on infant nutrition: follow-up cohort of a randomized clinical trial in western Gambia","volume":"13","author":"Roca","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0052","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/ciy254","article-title":"Long-term impact of oral azithromycin taken by Gambian women during labor on prevalence and antibiotic susceptibility of Streptococcus pneumoniae and Staphylococcus aureus in their infants: follow-up of a randomized clinical trial","volume":"67","author":"Bojang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0053","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/INF.0b013e31825c4b5a","article-title":"Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa","volume":"31","author":"Schrag","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0054","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijgo.2009.07.037","article-title":"Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia","volume":"107","author":"Aboud","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0055","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1542\/peds.2008-1873","article-title":"Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa","volume":"124","author":"Kafulafula","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.08.053","article-title":"Prophylactic antibiotics for the prevention of postpartum infectious morbidity in women infected with human immunodeficiency virus: a randomized controlled trial","volume":"198","author":"Sebitloane","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0057","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-3156.2011.02731.x","article-title":"Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ)","volume":"16","author":"Nunn","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0058","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijgo.2013.07.018","article-title":"Antibiotic prophylaxis in prelabor spontaneous rupture of fetal membranes at or beyond 36 weeks of pregnancy","volume":"124","author":"Nabhan","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0059","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3109\/14767058.2015.1052397","article-title":"Antibiotic prophylaxis to prevent postoperative infectious morbidity in low-risk elective Cesarean deliveries: a prospective randomized clinical trial","volume":"29","author":"Hong","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/QAI.0b013e31816856db","article-title":"Effect of trimethoprim\u2013sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania","volume":"47","author":"Morpeth","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0061","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/QAD.0b013e32833ac6bc","article-title":"Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa","volume":"24","author":"Hoffmann","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0062","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(10)60057-8","article-title":"Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort","volume":"375","author":"Walker","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0063","doi-asserted-by":"crossref","first-page":"156","DOI":"10.21010\/ajid.v10i2.12","article-title":"Effect of trimethoprim\u2013sulfamethoxazole prophylaxis on faecal carriage rates of resistant isolates of Escherichia coli in HIV-infected adult patients in Lagos","volume":"10","author":"Egwuatu","year":"2016","journal-title":"Afr J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001934","article-title":"Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1-infected adults in Kenya: a randomized non-inferiority trial","volume":"13","author":"Polyak","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206907","article-title":"Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): a randomised placebo controlled trial","volume":"13","author":"Anywaine","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0066","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.aids.0000174449.32756.c7","article-title":"Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members","volume":"19","author":"Mermin","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0067","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","article-title":"Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda","volume":"364","author":"Mermin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0068","doi-asserted-by":"crossref","first-page":"e17765","DOI":"10.1371\/journal.pone.0017765","article-title":"Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi","volume":"6","author":"Everett","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0069","first-page":"596","article-title":"Routine use of antimicrobial drugs during the 2004 cholera epidemic in Douala","volume":"83","author":"Noeske","year":"2006","journal-title":"Cameroon. East Afr Med J"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002593","article-title":"Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: a 3-arm, open-label, cluster-randomized trial","volume":"15","author":"Coldiron","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0071","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJMoa1408586","article-title":"Mass treatment with single-dose azithromycin for yaws","volume":"372","author":"Mitj\u00e0","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0072","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(18)30204-6","article-title":"Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study","volume":"391","author":"Mitj\u00e0","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0073","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2471\/BLT.10.084715","article-title":"Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics","volume":"89","author":"Lazzerini","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0074","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2352-3018(15)00005-3","article-title":"Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis","volume":"2","author":"Suthar","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0075","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.18-0846","article-title":"Mass azithromycin distribution to prevent childhood mortality: a pooled analysis of cluster-randomized trials","volume":"100","author":"Oldenburg","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0076","unstructured":"UNICEF. Malnutrition in children. https:\/\/data.unicef.org\/topic\/nutrition\/malnutrition\/#targetText=In%202018%20globally%2C%2049%20million,and%202.4%20per%20cent%2C%20respectively.,%20c%20https:\/\/data.worldbank.org\/indicator\/SH.DYN.AIDS.ZS [Accessed 23 April 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0077","unstructured":"World Bank. Fertility rate, total (births per woman). https:\/\/data.worldbank.org\/indicator\/SP.DYN.TFRT.IN [Accessed 23 April 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0078","unstructured":"World Bank. Prevalence of HIV, total (% of population ages 15\u201349).https:\/\/data.worldbank.org\/indicator\/SH.DYN.AIDS.ZS [Accessed 23 April 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0079","unstructured":"World Bank. Children (0\u201314) living with HIV. https:\/\/data.worldbank.org\/indicator\/SH.HIV.0014 [Accessed 23 April 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/cid\/cir067","article-title":"Does trimethoprim\u2013sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review","volume":"52","author":"Sibanda","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0081","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2214-109X(19)30540-6","article-title":"Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial","volume":"8","author":"Keenan","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0082","unstructured":"World Health Organization (WHO). Use of antibiotics in the outpatient management of children 6\u201359 months of age with severe acute malnutrition. https:\/\/www.who.int\/elena\/titles\/antibiotics_sam\/en\/ [Accessed 23 April 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0083","series-title":"WHO recommendations for prevention and treatment of maternal peripartum infections","year":"2015"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0084","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12884-015-0737-3","article-title":"Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: study protocol of a randomized efficacy trial","volume":"15","author":"Roca","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019170","article-title":"Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial)","volume":"7","author":"Pavlinac","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0086","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13063-019-3829-y","article-title":"A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol","volume":"21","author":"Study Team","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0087","article-title":"Hydroxychloroquine\/chloroquine as a treatment choice or prophylaxis for COVID-19 at the primary care level in developing countries: a primum non nocere dilemma","volume":"415","author":"Chevalier","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0088","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mib.2003.09.001","article-title":"Persistence of antibiotic resistant bacteria","volume":"6","author":"Andersson","year":"2003","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0089","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma","volume":"51","author":"Haug","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0090","first-page":"1736","article-title":"The effect of antibiotic selection pressure on the nasopharyngeal macrolide resistome: a cluster-randomized trial","volume":"67","author":"Keenan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0091","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1128\/AAC.00848-12","article-title":"Persistence of transferable extended-spectrum-\u03b2-lactamase resistance in the absence of antibiotic pressure","volume":"56","author":"Cottell","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106364_bib0092","doi-asserted-by":"crossref","first-page":"E11988","DOI":"10.1073\/pnas.1810840115","article-title":"Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora","volume":"115","author":"Tedijanto","year":"2018","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1016\/j.ijantimicag.2021.106396","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000}}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:06:30Z","timestamp":1699067190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857921001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0924857921001138"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106364","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijantimicag.2021.106396","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries. A systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106364"}}